glp 1 injection pen New Guidelines on GLP-1 Drugs for Obesity Released GLP-1 for Weight Loss: How

This created a difficult situation because many Medicare patients need these medications the most

Anthem BCBS coverage for Zepbound is similar to BCBS coverage of Zepbound in that it varies by plan

Many patients face: High out-of-pocket costs Insurance coverage limitations Supply shortages Side effects that make ongoing use difficult When treatment stops by choice or necessity patients are often left without a clear next step

She said the organization is in the process of drafting a new set of regulations related to obesity after soliciting feedback from experts in the field

In the SURMOUNT-1 trial with 2,539 adults with obesity, participants on the highest tirzepatide dose (15 mg weekly) lost an average of 20.9% of their body weight over 72 weeks